910 related articles for article (PubMed ID: 19839937)
1. The endocannabinoid system and pain.
Guindon J; Hohmann AG
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid mechanisms of pain modulation.
Hohmann AG; Suplita RL
AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the endocannabinoid system in the brain.
Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in brain reward processes.
Solinas M; Goldberg SR; Piomelli D
Br J Pharmacol; 2008 May; 154(2):369-83. PubMed ID: 18414385
[TBL] [Abstract][Full Text] [Related]
6. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
7. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG
Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
[TBL] [Abstract][Full Text] [Related]
8. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
10. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
[TBL] [Abstract][Full Text] [Related]
11. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
Sagar DR; Staniaszek LE; Okine BN; Woodhams S; Norris LM; Pearson RG; Garle MJ; Alexander SP; Bennett AJ; Barrett DA; Kendall DA; Scammell BE; Chapman V
Arthritis Rheum; 2010 Dec; 62(12):3666-76. PubMed ID: 20722027
[TBL] [Abstract][Full Text] [Related]
12. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events.
Sun X; Dey SK
Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid biosynthesis and inactivation, from simple to complex.
Muccioli GG
Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
[TBL] [Abstract][Full Text] [Related]
16. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
[TBL] [Abstract][Full Text] [Related]
18. Psychopharmacology of the endocannabinoids: far beyond anandamide.
Pamplona FA; Takahashi RN
J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids: synthesis and degradation.
Di Marzo V
Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
[TBL] [Abstract][Full Text] [Related]
20. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
